# A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects

> **NCT02096666** · PHASE1,PHASE2 · COMPLETED · sponsor: **Amgen** · enrollment: 11 (actual)

## Conditions studied

- Stomach Neoplasms

## Interventions

- **DRUG:** AMG 337

## Key facts

- **NCT ID:** NCT02096666
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-15
- **Primary completion:** 2015-11-05
- **Final completion:** 2018-12-07
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2021-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02096666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02096666, "A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT02096666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*